Design, synthesis, in silico and antiproliferative evaluation of novel pyrazole derivatives as VEGFR-2 inhibitors-Reference-Cited by-同舟云学术

Design, synthesis, in silico and antiproliferative evaluation of novel pyrazole derivatives as VEGFR-2 inhibitors

Published:2017-12-04 Issue:1 Volume:351 Page:1700234
ISSN:0365-6233
Container-title:Archiv der Pharmazie
language:en
Short-container-title:Arch. Pharm. Chem. Life Sci.

Author:

Ravula Parameshwar¹^ORCID,Vamaraju Harinadha Babu²,Paturi Manichandrika³,Sharath Chandra Janivara Nanjunde Gowda Narendra⁴

Affiliation:

1. Department of Pharmaceutical Chemistry, Guru Nanak Institutions Technical Campus, School of Pharmacy; Jawaharlal Nehru Technological University; Hyderabad India

2. Division of Medicinal Chemistry, G. Pulla Reddy College of Pharmacy; Osmania University; Hyderabad India

3. Department of Pharmaceutical Chemistry, Bojjam Narsimulu Pharmacy College for Women; Jawaharlal Nehru Technological University; Hyderabad India

4. Department of Pharmaceutical Chemistry, Bharat Institute of Technology, Pharmacy; Jawaharlal Nehru Technological University; Hyderabad India

Funder

University Grants Commission

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

Reference37 articles.

1. Cancer Statistics, 2008

2. Cancer Surpasses Heart Disease as Leading Cause of Death for All But the Very Elderly

3. Targeting multidrug resistance in cancer

4. Angiogenesis in health and disease

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The first-in-class pyrazole-based dual InhA-VEGFR inhibitors towards integrated antitubercular host-directed therapy;Bioorganic Chemistry;2024-04

2. Role of heterocycles in inhibition of VEGFR-2 – a recent update (2019–2022);RSC Medicinal Chemistry;2024

3. Rationale, in silico docking, ADMET profile, design, synthesis and cytotoxicity evaluations of phthalazine derivatives as VEGFR-2 inhibitors and apoptosis inducers;RSC Advances;2024

4. One‐Pot Synthesis of Isatin‐Pyrazole Hybrids as VEGFR‐2 Inhibitors and Molecular Docking Studies;ChemistrySelect;2023-02

5. Design, synthesis, and docking studies of novel pyrazole-based scaffolds and their evaluation as VEGFR2 inhibitors in the treatment of prostate cancer;RSC Advances;2023